Conventional Ultrasound Remains Effective Screening Tool for Women with Dense Breast Tissue, Research Suggests

Thursday, May 4, 2017

Aunt Minnie (5/3, Yee) reports “conventional ultrasound remains an effective screening tool in women with dense breast tissue, according to two presentations delivered at this week’s American Roentgen Ray Society (ARRS) meeting.” Researchers “found that ultrasound actually outperformed digital breast tomosynthesis (DBT) in women with heterogeneously or extremely dense tissue.” 

Risk for Lymphedema in Patients with Breast Cancer May Not Only be Linked to Surgery, Research Suggests

Monday, May 1, 2017

Medscape (4/28, Mulcahy) reported that research suggests “the risk for lymphedema in patients with breast cancer is not solely tied to surgery but is also associated with multiple other factors, including radiation therapy and chemotherapy.” The findings were presented at the American Society of Breast Surgeons annual meeting.

Ductal Carcinoma in Situ Patients Who Undergo Breast-Conserving Lumpectomy Surgery Have Small Risk of Second Contralateral Cancer, Study Suggests

Monday, May 1, 2017

Aunt Minnie (4/28) reports researchers found that only 2.8% of ductal carcinoma in situ patients “who underwent breast-conserving lumpectomy surgery...developed a second contralateral cancer after five years, and only 5.6% did so after 10 years,” according to a study presented the American Society of Breast Surgeons’ annual meeting. The study’s lead author suggested that based on the findings, bilateral mastectomy may be an overtreatment for many patients with ductal carcinoma in situ. 

JACR Study: Breast Cancers Found by Mammography Do Not Regress If Left Untreated

Monday, May 1, 2017
Breast cancers detected by mammography screening do not spontaneously disappear or regress if left untreated, according to a new study published in the Journal of the American College of Radiology (JACR®). The scientific findings contradict claims that many cancers found via mammography may simply “go away” if left undiscovered or untreated. 

FDA Issues Warning Letter to “Holistic” Practitioner Offering Thermography for Breast Cancer Detection

Monday, May 1, 2017
Thermography for breast cancer detection is one of more than 65 products the FDA just announced it is going after for fraudulently claiming to prevent, diagnose, treat or cure cancer.